发明名称 MODIFIED FACTOR IX
摘要 The invention in particular relates to the modification of human factor IX to result in factor IX proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo. The invention relates, furthermore, to T-cell epitope sequences deriving from human factor IX, which are immunogenic.
申请公布号 WO03020764(A2) 申请公布日期 2003.03.13
申请号 WO2002EP09717 申请日期 2002.08.30
申请人 MERCK PATENT GMBH;CARR, FRANCIS, J.;CARTER, GRAHAM 发明人 CARR, FRANCIS, J.;CARTER, GRAHAM
分类号 C12N15/09;A61K38/00;A61P7/04;A61P43/00;C07K7/06;C07K7/08;C07K14/745;C12N9/64;C12N15/57;C12P21/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址